quinidine has been researched along with amphotericin b in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (13.64) | 18.7374 |
1990's | 5 (22.73) | 18.2507 |
2000's | 4 (18.18) | 29.6817 |
2010's | 10 (45.45) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jolivette, LJ; Ward, KW | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Albert, C; Bringmann, G; Frank, A; Gulder, T; Holzgrabe, U; Moll, H; Ponte-Sucre, A; Rikanović, C; Schaeflein, L; Schultheis, M; Unger, M; Wegehaupt, A | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Bero, J; Frédérich, M; Leverrier, A; Palermo, J; Quetin-Leclercq, J | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chen, F; Chen, W; Lan, L; Li, B; Li, J; Liu, Y; Mao, F; Ni, S; Wei, H; Zhu, J | 1 |
Barza, M; Hashimoto, Y | 1 |
Backman, K; Germann, W; Harrison, B; Meysenberg, M; Schwartz, C | 1 |
Frindt, G; Windhager, EE | 1 |
Butt, AG; Clapp, WL; Frizzell, RA | 1 |
Dawson, DC; Ernst, SA; Germann, WJ | 1 |
Arruda, JA | 1 |
Guo, X; Hopfer, U; Laboisse, CL; Merlin, D | 1 |
Berger, A; Broillet, MC; Horisberger, JD | 1 |
Plass, H; Turnheim, K; Wyskovsky, W | 1 |
1 review(s) available for quinidine and amphotericin b
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
21 other study(ies) available for quinidine and amphotericin b
Article | Year |
---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Structure-activity relationship and studies on the molecular mechanism of leishmanicidal N,C-coupled arylisoquinolinium salts.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Humans; Isoquinolines; Leishmania major; Leishmaniasis; Macrophages; Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Antiparasitic hybrids of Cinchona alkaloids and bile acids.
Topics: Antiparasitic Agents; Bile Acids and Salts; Cell Line; Cinchona Alkaloids; Humans; Inhibitory Concentration 50 | 2013 |
Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity.
Topics: Animals; Drug Design; Enzyme Inhibitors; ERG1 Potassium Channel; HEK293 Cells; Hep G2 Cells; Humans; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Mice; Oxidoreductases; Rats; Safety; Solubility; Structure-Activity Relationship; Water | 2018 |
Effect of quinidine together with antibiotics on contractility of cat papillary muscle.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Cats; Depression, Chemical; Gentamicins; In Vitro Techniques; Myocardial Contraction; Papillary Muscles; Quinidine; Tetracycline | 1975 |
Inactivation of a volume-sensitive basolateral potassium conductance in turtle colon: effect of metabolic inhibitors.
Topics: Amphotericin B; Animals; Cell Membrane; Chlorides; Colon; Electrophysiology; Epithelium; Intestinal Mucosa; Potassium Channels; Quinidine; Sucrose; Sulfuric Acids; Turtles | 1992 |
Ca2(+)-dependent inhibition of sodium transport in rabbit cortical collecting tubules.
Topics: Amphotericin B; Animals; Biological Transport; Calcium; Cell Membrane; Desoxycorticosterone; Electric Conductivity; Ionomycin; Kidney Tubules; Kidney Tubules, Collecting; Osmolar Concentration; Quinidine; Rabbits; Sodium; Vasopressins | 1990 |
Potassium conductances in tracheal epithelium activated by secretion and cell swelling.
Topics: Amphotericin B; Animals; Barium; Bumetanide; Cell Membrane; Chlorides; Dogs; Electric Conductivity; Epinephrine; Epithelium; In Vitro Techniques; Kinetics; Mucous Membrane; Ouabain; Potassium; Potassium Channels; Quinidine; Rubidium; Trachea | 1990 |
Resting and osmotically induced basolateral K conductances in turtle colon.
Topics: Amphotericin B; Animals; Anions; Benzenesulfonates; Colon; Epithelial Cells; Epithelium; Ion Channels; Membranes; Mucous Membrane; Osmolar Concentration; Osmotic Pressure; Potassium; Quinidine; Rest; Rubidium; Turtles | 1986 |
Characterization of the effect of quinidine on Na transport by the toad and turtle bladders.
Topics: Amiloride; Amphotericin B; Animals; Bufo marinus; Calcium; Drug Interactions; Ion Channels; Mitochondria, Liver; Quinidine; Sodium; Turtles; Urinary Bladder | 1983 |
Ca2+ and cAMP activate different K+ conductances in the human intestinal goblet cell line HT29-Cl.16E.
Topics: Amphotericin B; Barium; Bumetanide; Calcimycin; Calcium; Carbachol; Cell Line; Cell Membrane Permeability; Colforsin; Cyclic AMP; Digitonin; Diphenylamine; Electric Conductivity; Epithelial Cells; Epithelium; Fura-2; Humans; Intestinal Mucosa; Membrane Potentials; Models, Biological; Ouabain; Potassium; Potassium Channels; Quinidine; Tetradecanoylphorbol Acetate; Thionucleotides; Vasoactive Intestinal Peptide | 1995 |
Early effects of aldosterone on the basolateral potassium conductance of A6 cells.
Topics: Aldosterone; Amphotericin B; Animals; Cell Line; Cell Membrane Permeability; Electric Conductivity; Epithelium; Kidney; Kinetics; Potassium Channels; Quinidine; Xenopus laevis | 1993 |
Basolateral potassium channels of rabbit colon epithelium: role in sodium absorption and chloride secretion.
Topics: Adenosine-5'-(N-ethylcarboxamide); Amphotericin B; Animals; Cell Membrane; Chlorides; Colon; Dose-Response Relationship, Drug; Electric Conductivity; Epithelium; In Vitro Techniques; Intestinal Absorption; Patch-Clamp Techniques; Potassium; Potassium Channel Blockers; Potassium Channels; Quinidine; Rabbits; Sodium; Verapamil | 2002 |